|
All
Wonder Oil products and shopping cart are at:
www.wonderoil.com
| |
|
| |
Wonder
Oil Products, Inc.
PO
Box 5808
Napa,
CA 94581
Information:
707-252-7555
emuoil@gte.net |
| |
|
|
|
Emu
Oil Research
Skin
Care and Emu Oil
Moist.
& Cosmetic Properties
Moisturizing
and Cosmetic
Properties Of Emu Oil:
A Double Blind Study
Presented at the AEA national convention in
Nashville, Tennessee. August 1994
Alexander Zemtsov, M.D., M.S. Indiana University School of Medicine
Monica Gaddis, Ph.D. Ball Memorial Hospital
Victor Montalvo-Lugo, M.S. Ball Memorial Hospital
Summary
Cosmetic and moisturizing properties of emu oil were assessed in a
double blind clinical study. Emu oil in comparison to mineral oil
was found overall to be more cosmetically acceptable (p<0.05).
Furthermore, it appears that emu oil in comparison to mineral oil
has better moisturizing properties, superior texture, and lower incidence
of comedogenicity, but probably because of the small sample size these
differences, were not found to be statistically significant (p<0.05).
Neither of the oils were found to be irritating to the skin. Finally,
emu oil fatty acid composition was studied by gas chromatography and
was found to have high concentration of nonpolar monounsaturated fatty
acids which may explain emu oil's ability to penetrate easily through
the stratum corneum barrier.
Introduction
The emu, a large flightless bird, Dromaius novaehollandiae, is probably
best known for being on Australia's coat of arms opposite the kangaroo.
In the past few years commercial emu breeding has become a multi-million
dollar industry in the United States, Australia, and other countries.
Emu oil derived from emu fat was being used by the Aborigines for
healing and pain control long before British ships landed on the eastern
shores of Australia.
A number
of Australian investigators (George Hobday, M.D., a dermatologist
and Peter Ghosh, Ph.D., FRSC at the University of Sydney) claimed
that emu oil has anti-inflammatory and skin penetrating properties.
Recently the Australian Department of health classified emu oil as
a pharmaceutical product1 and registered emu oil in the Therapeutic
Goods Registry2. Finally an official Australian government publication
stated "the oil (emu) will find uses in the pharmaceutical and
cosmetic industries". We performed an extensive literature search
(Medline, Index Medicus) and could not find a single report in scientific
peer reviewed literature dealing with either emu oil and its cosmetic
pharmaceutical properties of its composition1. A pilot double blind
study was conducted to assess cosmetic properties of emu oil - namely
its moisturizing and skin penetrating properties, texture and odor,
andirritancy and comedogenicity potential. The emu oil was compared
in this study to mineral oil, a synthetic oil that is widely used
in the United States as an emulsifier and lubricant in topical cosmetical
and pharmaceutical preparations.
Methods
Human Subjects
11 subject were recruited and completed the study (9 women and 2 men).
Mean age was 35 years (age range 25-52), 10 subjects were white Caucasian
and one subject was Hispanic. All had Fitzpatrick skin type 2 or 3
based in history of response to UV radiation. All had healthy skin
and people with eczema and acne were specifically excluded from this
study. Since both emu and mineral oil can be purchased in the United
States over the counter, no human subject research permit was required
of issued by the Texas tech Human Subject Institutional Review Board.
Oil:
Emu oil for clinical study was imported from Australia (Emu Vertica,
Thalgo Holdings Pty. Ltd.). Both Australian emu and mineral oil were
placed in dark, numbered bottles by a pharmacist (Caprock Drugs, Lubbock,
TX). Neither human subjects or principal investigator knew which oil
each subject was using at what particular time. The code was not broken
until all volunteers completed the study and returned the questionnaire
to the principal investigators.
Oil Composition:
Fatty acid analysis by gas chromatograph was performed by Dr.. Margaret
Craig-Schmidt's laboratory of Auburn University and the results were
reported in the AEA News September, 1994.
Protocol:
Prior to entering the study each subject was examined by a university
based dermatologist to make sure that none of the volunteers had eczema
or acne. The volunteers were instructed to use the first oil on their
face and trunk twice a day for 2 weeks. The human subjects were told
to discontinue use of any other lubricants. After 2 weeks of oil use
the human subjects were briefly examined by the principal investigator
for signs of skin irritation or acne and at that time were given a
second oil. The pharmacist made sure that each subject received both
emu oil and mineral oil. At the end on the study each subject completed
the questionnaire and ranked on a 0 to 5 scale (5 excellent; 0 poor)
how much they liked each oil. There were also asked to rank its penetration/permeability,
moisturizing properties, texture, and any side effects (comedogenicity,
odor, irritancy, etc.)
Statistical
Analysis:
The data generated was in a created ranking scale format [0 (poor);
5 (excellent)] and was analyzed by a biostatistician utilizing the
Wilcoxan Signed ranking test.
Results
As shown in Table I, the emu oil overall ranking and permeability
was found to be clearly superior to mineral oil. These differences
in skin penetration/permeability and overall ranking were statistically
significant (p<0.05). It also appears that emu oil texture and
moisturizing properties as judged by the participants in the study
were also superior to mineral oil, but the differences cannot be considered
statistically significant (p>0.05). The sample size was small (n=11)
and it is very possible that if more people participated in the study
the clear cut statistical differences in the oils texture and moisturizing
properties would have been found.
When the
participants in this study were asked which of the two oils they liked
better, all 11 subjects (100%) stated that they liked emu oil better
(Table II). Neither emu oil or mineral oil was found to be irritating
to the skin (0%, Table II). Finally, when the oils were applied to
the face, 6 people (55%) and 2 people (18%) reported the mineral and
emu oil respectively caused "pimples", (Table II).
Discussion
This pilot, a double blind crossover study, clearly indicated that
emu oil may become widely used in cosmetic and pharmaceutical industries.
We found emu oil to be totally non-irritating, having excellent moisturizing
properties, cosmetically pleasing texture, and low incidence of comedoginicity.
The most intriguing properties of emu oil as far as cosmetic and pharmaceutical
industries are concerned is its apparent ability to penetrate the
stratum corneum barrier. The study of penetration of various substances
through the skin is an area of an active research and is obviously
important from the therapeutical and toxicological viewpoints. Iontophorisis3
, and liposome preparations4,5 are actively studied as a means to
increase cutaneous bioavailability. Since most topical vehicles have
an absorption rate of only a few percent6 the drugs and other active
ingredients combine with more efficient drug carrier systems are of
major interest to cosmetic and pharmaceutical industries. As a matter
of fact, liposome preparations containing the anti-fungal agent econzole
(econazole 1%; pevarly; cilag; Schafflausen, Switzerland) and cosmetics
with liposene base are now available in the United States and Western
Europe4,5.
Unfortunately,
because of high cost and other technical problems neither liposome
or iontophorisis are now widely used in either cosmetic or dermatological
topical preparations3,4 . If indeed, as we report in this paper, emu
oil has superb skin penetrating properties, as judged subjectively
by participants in this study, and because of relatively low cost,
emu oil should be of major interest to dermatologists and cosmetic
scientists as a transcutaneous carier system. It would not be unreasonable
to try to combine emu oil with topical antifungals, steroids, retinoids,
antihistamines, anesthetics, antiangrogen, and immunosuppressive drugs
to see if emu oil improves cutaneous bioavailability.
Even prior
to completion of this study a number of investigators became aware
of apparent penetrating properties emu oil. As was noted in the methods
section of this article, the composition of emu oil was studied by
Dr. Craig-Schmidt utilizing gas chromatography. The findings were
that emu oil is predominately composed of short chain monounsaturated
fatty acids slowing it to easily penetrate the stratum corneum. Another
investigator utilizing thin layer chromatography (TLC) found that
emu oil is essentially free of phospholipids thus enabling it to penetrate
readily through skin (Allen Strickland, personal communication).
We believe
that this apparently first scientifically conducted study addressing
cosmetic and pharmaceutical properties of emu oil is very promising.
We are in the process of organizing in the United States a much larger
multicenter similar double blind study to confirm our findings. Furthermore,
Dr. Craig-Schmidt's research group is in the process of conducting
in-vitro transmembraneous skin penetration studies with emu oil to
determine its transcutaneous permeability. We hope that this and the
future study with emu oil to determine its transcutaneous permeability.
We hope that this and the future study mentioned above will fully
assess the cosmetic, moisturizing, and pharmaceutical properties of
emu oil.
References
1 Commonwealth of Australia, Department of Health, Hosing and
Community Services, Certificate of a pharmaceutical Product No 92/0980
2 AUST R 22759 in the Australian Register of Therapeutical
Goods.
3 Singh J, Mabach HI. Topical Iontophoretic Drug Delivery in
vivo: Historical Development, Devices, and Future Respectives. Dermatology
1993: 187:235-238.
4 Korting HC, Blechek P, schaefer-Korting M, Wendel A. topical
liposome drugs to come: What the patent literature tells us. A review,
J Am Academy of Dermatoloy 1991; 15:1068-1071.
5 Schaefer-Korting M, Korting HC, Braun-Falco O. Liposome Preparations;
A step forward in topical drug therapy for skin disease: A Review,
J Am Academy of Dermatology 1989; 21:1271-1275.
6 Wester RC, Maibach HI. Dermatopharmokinetics in clinical
Dermatology. Semin Dermatol 1983; 2:81-84
All correspondence should be addressed to: Alexander Zemtsov, M.D.,
M.S., Research Dept., Ball Memorial Hospital, 2401 University Ave.,
Muncie, IN 47303-3499. Phone (317)747-8458 of (317 741-1975. Fax (317)747-8459.
This work was supported by a grant from the American Emu Association,
Dallas, TX.

|